Abpro Holdings IPO Amendment Filed

Ticker: ABPWW · Form: S-1/A · Filed: Feb 7, 2025 · CIK: 1893219

Sentiment: neutral

Topics: ipo, amendment, biotech

TL;DR

Abpro Holdings IPO amendment filed Feb 7, 2025. Formerly Atlantic Coastal Acquisition Corp. II. Biotech play.

AI Summary

Abpro Holdings, Inc. filed an S-1/A amendment on February 7, 2025, for its initial public offering. The company, previously known as Atlantic Coastal Acquisition Corp. II, is a biotechnology firm focused on developing antibody-based therapeutics. The filing provides updated information for its IPO, though specific dollar amounts for the offering are not detailed in this excerpt.

Why It Matters

This filing is a step in Abpro Holdings' process to become a publicly traded company, which could provide it with capital for research and development and impact the biotechnology investment landscape.

Risk Assessment

Risk Level: medium — Biotechnology IPOs carry inherent risks due to the speculative nature of drug development and market volatility.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Abpro Holdings, Inc.?

Abpro Holdings, Inc. is focused on the development of antibody-based therapeutics, as indicated by its SIC code for Biological Products.

When was this amendment filed?

This amendment (S-1/A) was filed on February 7, 2025.

What was Abpro Holdings, Inc. formerly known as?

Abpro Holdings, Inc. was formerly known as Atlantic Coastal Acquisition Corp. II.

Where is Abpro Holdings, Inc. principal executive office located?

The principal executive offices are located at 68 Cummings Park Drive, Woburn, MA 01801.

Who is the Chief Executive Officer of Abpro Holdings, Inc.?

Ian Chan is the Chief Executive Officer of Abpro Holdings, Inc.

Filing Stats: 4,701 words · 19 min read · ~16 pages · Grade level 16.7 · Accepted 2025-02-07 17:18:25

Key Financial Figures

Filing Documents

From the Filing

As filed with the U.S. Securities and Exchange Commission on February 7, 2025 Registration No. 333-284021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abpro Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 2834 87-1013956 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) 68 Cummings Park Drive Woburn, MA 01801 Tel: 1-800-396-5890 (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Executive Offices) Ian Chan Chief Executive Officer 68 Cummings Park Drive Woburn, MA 01801 Tel: 1-800-396-5890 (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service) Copies to: Jonathan H. Talcott E. Peter Strand Michael K. Bradshaw, Jr. Nelson Mullins Riley & Scarborough LLP 101 Constitution Ave NW, Suite 900 Washington, DC 20001 Telephone: (202) 689-2800 Approximate date of commencement of proposed sale to public: From time to time after the effective date hereof. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. The registrant hereby amends this registration specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act or until the registration statement shall become effective on such date as the SEC, acting pursuant to Section 8(a) of the Securities Act, may determine. The information contained in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted. PRELIMINARY PROSPECTUS DATED FEBRUARY 7, 2025 Abpro Holdings, Inc. Primary Offering of Up to 28,850,000 shares of Common Stock Upon the Exercise of Warrants Secondary Offering of Up to 31,935,312 shares of Common Stock Up to 13,850,000 Warrants This prospectus relates to the primary issuance by us of up to an aggregate of 28,850,000 shares of Common Stock, par value $0.0001 per share (the " Common Stock "), of Abpro Holdings, Inc. (the " Company " or " New Abpro "), which consists of (i) up to 15,000,000 shares of Common Stock issuable upon the exercise of 15,000,000 warrants, at an exercise price of $11.50 per share (the " Public Warrants ") originally issued in the initial public offering of Atlantic Coastal Acquisition Corp. II (" ACAB ") and (ii) up to an aggregate of 13,850,000 shares of Common Stock issuable upon the exercise of 13,850,000 warrants, at an exercise price of $11.50 per share (the " Placement Warrants ", and together with the Public Warrants, the " Warrants ") that made up part of the private units originally issued in a private placement in connection with ACAB's initial public offering (the " ACAB IPO "). We will receive the proceeds from any exercise of the Warrants for cash. This prospectus also relates to the offer and resale from t

View Full Filing

View this S-1/A filing on SEC EDGAR

View on Read The Filing